Aperio Group, LLC - MERIDIAN BIOSCIENCE INC ownership

MERIDIAN BIOSCIENCE INC's ticker is VIVO and the CUSIP is 589584101. A total of 177 filers reported holding MERIDIAN BIOSCIENCE INC in Q4 2015. The put-call ratio across all filers is 1.00 and the average weighting 0.1%.

Quarter-by-quarter ownership
Aperio Group, LLC ownership history of MERIDIAN BIOSCIENCE INC
ValueSharesWeighting
Q4 2020$575,000
+13.0%
30,763
+2.6%
0.00%0.0%
Q3 2020$509,000
-26.0%
29,979
+1.5%
0.00%
-33.3%
Q2 2020$688,000
+183.1%
29,533
+2.1%
0.00%
+200.0%
Q1 2020$243,000
-22.1%
28,938
-9.2%
0.00%0.0%
Q4 2019$312,000
+33.3%
31,858
+29.5%
0.00%0.0%
Q3 2019$234,000
-43.1%
24,595
-28.9%
0.00%
-50.0%
Q2 2019$411,000
-51.0%
34,599
-27.3%
0.00%
-50.0%
Q1 2019$838,000
+3.8%
47,598
+2.3%
0.00%0.0%
Q4 2018$807,000
+32.5%
46,522
+13.8%
0.00%
+33.3%
Q3 2018$609,000
-10.8%
40,869
-4.9%
0.00%0.0%
Q2 2018$683,000
-6.6%
42,965
-16.5%
0.00%
-25.0%
Q1 2018$731,000
+16.8%
51,469
+15.3%
0.00%
+33.3%
Q4 2017$626,000
-8.6%
44,650
-6.8%
0.00%
-25.0%
Q3 2017$685,000
-15.3%
47,902
-6.8%
0.00%
-20.0%
Q2 2017$809,000
+59.9%
51,385
+40.0%
0.01%
+66.7%
Q1 2017$506,000
+102.4%
36,703
+159.5%
0.00%
+50.0%
Q4 2016$250,000
-18.0%
14,143
-10.5%
0.00%0.0%
Q3 2016$305,000
+18.2%
15,809
+19.7%
0.00%0.0%
Q2 2016$258,000
-21.6%
13,207
-17.2%
0.00%
-33.3%
Q1 2016$329,000
+23.7%
15,942
+23.0%
0.00%
+50.0%
Q4 2015$266,000
+13.7%
12,956
-5.5%
0.00%0.0%
Q3 2015$234,000
+3.1%
13,704
+12.5%
0.00%0.0%
Q2 2015$227,000
-6.6%
12,176
-4.2%
0.00%
-33.3%
Q1 2015$243,00012,7120.00%
Other shareholders
MERIDIAN BIOSCIENCE INC shareholders Q4 2015
NameSharesValueWeighting ↓
Euclidean Technologies Management, LLC 115,571$3,034,0002.64%
Acuitas Investments, LLC 160,046$4,201,0002.41%
HUSSMAN STRATEGIC ADVISORS, INC. 144,000$3,780,0000.78%
GLOBEFLEX CAPITAL L P 158,664$4,165,0000.76%
CLARK ESTATES INC/NY 220,000$5,775,0000.74%
SYSTEMATIC FINANCIAL MANAGEMENT LP 721,176$18,931,0000.69%
EARNEST PARTNERS LLC 4,341,834$113,973,0000.68%
MOODY ALDRICH PARTNERS LLC 138,844$3,645,0000.53%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 889,269$23,343,0000.49%
Phocas Financial Corp. 134,740$3,537,0000.47%
View complete list of MERIDIAN BIOSCIENCE INC shareholders